Mylan N.V. (NASDAQ:MYL) has been given a $32.00 price objective by equities researchers at Wells Fargo & Company in a report issued on Wednesday. The brokerage presently has a “hold” rating on the stock. Wells Fargo & Company’s price target would suggest a potential downside of 15.61% from the company’s current price.

Other research analysts have also issued research reports about the company. UBS AG reaffirmed a “buy” rating and set a $46.00 price target (down previously from $50.00) on shares of Mylan N.V. in a research report on Thursday, August 10th. Citigroup Inc. raised Mylan N.V. from a “neutral” rating to a “buy” rating and upped their price target for the company from $36.00 to $42.00 in a research report on Wednesday, August 16th. Mizuho reaffirmed a “buy” rating and set a $37.00 price target (down previously from $53.00) on shares of Mylan N.V. in a research report on Sunday, August 20th. BMO Capital Markets reaffirmed a “buy” rating and set a $45.00 price target on shares of Mylan N.V. in a research report on Friday, September 29th. Finally, ValuEngine raised Mylan N.V. from a “hold” rating to a “buy” rating in a research report on Monday. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating, twelve have given a buy rating and one has given a strong buy rating to the company’s stock. Mylan N.V. currently has an average rating of “Buy” and a consensus price target of $42.04.

Shares of Mylan N.V. (NASDAQ:MYL) traded up 0.32% during midday trading on Wednesday, reaching $37.92. The company’s stock had a trading volume of 11,211,385 shares. The company’s 50-day moving average price is $31.86 and its 200 day moving average price is $36.48. The company has a market capitalization of $20.34 billion, a P/E ratio of 30.65 and a beta of 1.30. Mylan N.V. has a 12-month low of $29.39 and a 12-month high of $45.87. Mylan N.V. also saw some unusual options trading on Wednesday. Stock investors acquired 10,562 put options on the stock. This represents an increase of 461% compared to the typical volume of 1,883 put options.

Mylan N.V. (NASDAQ:MYL) last released its quarterly earnings results on Wednesday, August 9th. The company reported $1.10 EPS for the quarter, missing analysts’ consensus estimates of $1.18 by ($0.08). The business had revenue of $2.96 billion for the quarter, compared to the consensus estimate of $3 billion. Mylan N.V. had a net margin of 5.51% and a return on equity of 22.42%. The company’s revenue for the quarter was up 15.7% on a year-over-year basis. During the same period in the previous year, the company earned $1.16 EPS. On average, equities research analysts forecast that Mylan N.V. will post $4.52 earnings per share for the current year.

WARNING: “Wells Fargo & Company Analysts Give Mylan N.V. (MYL) a $32.00 Price Target” was first published by American Banking News and is the sole property of of American Banking News. If you are reading this piece of content on another site, it was illegally copied and reposted in violation of US & international trademark and copyright legislation. The correct version of this piece of content can be read at https://www.americanbankingnews.com/2017/10/04/mylan-n-v-myl-given-market-perform-rating-at-wells-fargo-company.html.

A number of hedge funds have recently bought and sold shares of MYL. Waldron LP bought a new position in Mylan N.V. during the 1st quarter valued at approximately $229,000. UBS Asset Management Americas Inc. increased its position in Mylan N.V. by 13.7% during the 1st quarter. UBS Asset Management Americas Inc. now owns 1,179,217 shares of the company’s stock valued at $45,978,000 after buying an additional 142,124 shares in the last quarter. Sei Investments Co. increased its position in Mylan N.V. by 1.0% during the 1st quarter. Sei Investments Co. now owns 13,870 shares of the company’s stock valued at $541,000 after buying an additional 134 shares in the last quarter. KBC Group NV increased its position in Mylan N.V. by 27.5% during the 1st quarter. KBC Group NV now owns 49,272 shares of the company’s stock valued at $1,921,000 after buying an additional 10,638 shares in the last quarter. Finally, Blair William & Co. IL increased its position in Mylan N.V. by 20.3% during the 1st quarter. Blair William & Co. IL now owns 9,591 shares of the company’s stock valued at $401,000 after buying an additional 1,616 shares in the last quarter. 71.97% of the stock is owned by institutional investors.

About Mylan N.V.

Mylan N.V. is a global pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic and branded generic products for resale by others; specialty pharmaceuticals, and active pharmaceutical ingredients (APIs). It operates through two segments: Generics and Specialty.

Analyst Recommendations for Mylan N.V. (NASDAQ:MYL)

Receive News & Ratings for Mylan N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mylan N.V. and related companies with MarketBeat.com's FREE daily email newsletter.